The COX-2 and iNOS signalings are implicated in the regulation of proliferation, apoptosis, migration and invasion responses in many kinds of cancer cells, and their inhibitors have been improved to be able to block survival signaling to accelerate killing tumor cells. This evidence concerns the gene NOS2 and cancer.